Included parameters | Disease-free survival | Overall survival | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value | |
T stage | Â | Â | 0.014 | Â | Â | 0.040 |
  T1 versus T2-3 | 2.123 | 1.167-3.861 |  | 1.829 | 1.028-3.255 |  |
N stage | Â | Â | 0.001 | Â | Â | 0.011 |
  N0 versus N1-3 | 2.344 | 1.389-3.956 |  | 1.971 | 1.166-3.333 |  |
Histologic grade | Â | Â | 0.632 | Â | Â | 0.545 |
  I/II versus III | 1.143 | 0.661-1.977 |  | 0.839 | 0.475-1.482 |  |
ER status | Â | Â | 0.111 | Â | Â | 0.079 |
  Negative versus Positive | 1.795 | 0.874-3.686 |  | 1.888 | 0.929-3.836 |  |
PR status | Â | Â | 0.198 | Â | Â | 0.070 |
  Negative versus Positive | 1.638 | 0.773-3.473 |  | 2.036 | 0.944-4.393 |  |
HER-2 status | Â | Â | 0.469 | Â | Â | 0.508 |
  Negative versus Positive | 1.235 | 0.697-2.188 |  | 1.214 | 0.683-2.159 |  |
GNMT | Â | Â | 0.019 | Â | Â | 0.272 |
  Negative versus Positive | 2.408 | 1.154-5.024 |  | 1.622 | 0.684-3.849 |  |
PIPOX (T) | Â | Â | 0.069 | Â | Â | 0.563 |
  Negative versus Positive | 0.457 | 0.196-1.064 |  | 0.810 | 0.397-1.652 |  |